BrandWikiReturn

Tilray

WorldBrand briefing

AI supplement

Original synthesis to sit alongside the encyclopedia article below. Not part of Wikipedia; verify facts on Wikipedia when precision matters.

Tilray是一家总部位于美国纽约的全球大麻及消费品企业，业务覆盖医用和成人用大麻、精酿啤酒、健康食品、饮料等品类，在全球20余个国家拥有超40个合作品牌，是全球医用大麻领域的领军生产商之一。

Key moments

  • 2014Tilray正式成立，专注医用大麻研发与种植
  • 2018在纳斯达克和多伦多证券交易所上市，成为首批公开上市的加拿大大麻企业之一
  • 2020年起先后完成多起并购，包括收购Aphria、SweetWater Brewery、Manitoba Harvest等，拓展饮料、食品等消费品赛道
  • 2023年后持续拓展全球市场，在欧洲、澳洲、拉美等地布局生产与销售网络

Tilray的竞争格局分析

  1. 核心竞品对比：与Canopy Growth、Aurora Cannabis等同为加拿大头部大麻企业相比，Tilray更早布局全球医用大麻市场，且通过并购快速扩充消费品品类，形成了大麻+健康食品+精酿饮品的多线业务结构。
  2. 差异化优势：凭借GMP认证的生产标准和全球20国的合规布局，在医用大麻领域拥有较强的品牌认可度；同时通过收购传统消费品品牌，规避了单一品类的周期波动风险。
  3. 行业挑战：全球大麻监管政策仍存在区域差异，部分市场的合法化进程缓慢，同时行业内同质化产品竞争激烈，需要持续投入研发创新产品形态。
  • 业务覆盖医用大麻、消费品多个赛道，抗风险能力强于单一大麻企业
  • 全球布局较早，拥有成熟的跨境供应链和合规运营经验
  • 2021年因Reddit散户抱团行情成为知名 meme 股，股价波动幅度较大

Tilray is a globally recognized pioneer in the regulated cannabis industry, with a diversified brand portfolio spanning medical cannabis, adult-use cannabis, craft beer, health foods, and beverages. Headquartered in New York, the company has established itself as a leading player in the global medical cannabis segment, leveraging early mover advantage and stringent production standards to build brand trust across multiple regulated markets.

The company’s strategic growth through acquisitions has allowed it to expand beyond core cannabis operations into broader consumer packaged goods, creating a diversified business model that mitigates the regulatory and cyclical risks associated with the cannabis sector. This diversification has helped strengthen overall brand equity by connecting with consumers across multiple lifestyle and wellness categories.

While the global cannabis industry continues to face uneven regulatory landscapes across regions, Tilray’s long-standing focus on compliance and medical cannabis research has positioned it as a respected brand among both institutional stakeholders and end consumers, supporting ongoing brand development amid industry evolution.

Brand leadership

Score: 85/100

As a top-tier player in the global medical cannabis market, Tilray holds strong brand leadership, backed by its GMP-certified production standards and early entry into regulated markets. It is recognized as a pioneer among global cannabis firms, outranking many peers in geographic reach and medical cannabis credibility among healthcare partners and patients.

Brand interaction

Score: 70/100

Tilray maintains active brand interaction across consumer segments, running patient education initiatives for medical cannabis, and marketing campaigns for its craft beer and wellness product lines across digital and retail channels, building consistent engagement with diverse audience groups.

Brand momentum

Score: 65/100

Against the backdrop of uneven cannabis legalization progress globally, Tilray continues to enter newly legalized markets and expand its product innovation pipeline, while its diversified consumer business supports steady brand momentum, offsetting slowdowns in any single market segment.

Brand stability

Score: 72/100

Tilray's diversified business structure, which combines cannabis operations with non-cannabis consumer goods, reduces its exposure to the regulatory and market volatility that impacts pure-play cannabis companies, delivering more stable brand performance and consistent equity growth over time.

Brand age

Score: 60/100

Founded in 2014, Tilray is a relatively young brand compared to long-established traditional consumer goods companies, but it has built a recognizable operating presence and brand identity over 12+ years in the emerging legal cannabis industry, reaching a solid stage of brand maturity.

Industry profile

Score: 78/100

As one of the first large publicly traded global cannabis companies, Tilray has a prominent industry profile, widely recognized by investors, industry observers and regulators as a leading example of global expansion and business diversification in the legal cannabis sector.

Globalization

Score: 82/100

Tilray operates across more than 20 countries worldwide, with over 40 partner brands and localized compliance frameworks in North America, Europe, and other regions, giving it one of the most geographically diversified footprints of any global cannabis company.

AI can support preliminary reasoning around Tilray's brand value, and any illustrative figures referenced in supplementary materials are for general informational purposes only. For a fully audited, professional brand value assessment and detailed valuation analysis for Tilray, please contact the World Brand Lab directly.

Tilray Brands, Inc. is an American pharmaceutical, cannabis-lifestyle and consumer packaged goods company, incorporated in the United States, headquartered in New York City.[1][2] Tilray also has operations in Canada, Australia, New Zealand,[3][4]Latin America,[5] with growing facilities in Germany, Portugal and the United Kingdom.[6][7]

In December 2020, the company announced a merger with Aphria, and now operates under the Tilray name and its ticker symbol on NASDAQ[8] and the Toronto Stock Exchange.[9]

Tilray also owns several breweries and was ranked by the Brewers Association as the 4th largest craft beer company in the US in 2025.

History

Founded in 2013, Tilray was originally incorporated under the umbrella of Seattle-based Privateer Holdings and was one of Canada's first licensed producers.[10][11] At the end of 2014, it secured the first institutional investment in the cannabis industry from Founders Fund, a San Francisco-based venture capital fund.[10] In 2016, it became the first cannabis company to conduct a clinical trial approved by Health Canada.[10] The trial evaluated the therapeutic potential of medical cannabis.[10] In January 2017, Tilray was certified for good manufacturing practices.[12]

By October 2018, the company had raised $1.1 billion.[10] In July 2018, it became the first cannabis company to trade publicly on a major U.S. stock exchange,[13] opening on the NASDAQ exchange at a price of $17 per share, which increased in September 2018 to $214 per share, and then descended to $29 per share by August 2019.[14][15] The IPO raised US$153 million.[16]

In September 2018, Tilray became the first Canadian cannabis company to legally export medical cannabis to the U.S. for a clinical trial.[17] In December 2018, the company signed a deal with Novartis subsidiary Sandoz to sell, distribute and co-brand Tilray's non-smokeable/non-combustible medical cannabis products in legal markets worldwide.[18] On June 19, 2018, Tilray announced the launch of High Park Company which operates in the adult recreational cannabis market to establish unique adult-use brands in Canada.[19]

Since September 2022, Tilray has been licensed by the Polish and Italian Ministries of Health to import and distribute THC25 medical cannabis throughout Poland and Italy.[20]

In August 2023, Tilray acquired eight beverage brands in addition to the breweries of the brands from Anheuser-Busch for $85 million.[21]

Strategic partnerships and acquisitions

In 2018, Tilray announced it had entered into global alliance with Sandoz, a division of Novartis to co-brand and distribute non-combustible medical cannabis products in global markets where it is legally authorized. The Globe and Mail dubbed this partnership as ‘big-pharma’s first foray into cannabis’.[22]

Also in 2018, Tilray announced a $100-million joint venture with the world's largest brewer, AB InBev to research non-alcohol tetrahydrocannabinol (THC) and cannabidiol (CBD)-infused beverages, through their respective subsidiaries, Labatt Breweries and High Park Company.[23]

In 2019, Tilray signed a $250 million revenue-sharing deal with U.S. based brand company, Authentic Brands Group, to leverage ABG brand names, such as Juicy Couture, Greg Norman, and Nine West to create cannabis products. ABG has a portfolio of over 50 brands.[24]

In February 2019, Tilray acquired Manitoba Harvest, a hemp foods manufacturer, for $317 million from Compass Diversified Holdings.[25] The acquisition allowed Tilray to use Manitoba Harvest's retail distribution network to enter the U.S. CBD market.[26] Manitoba Harvest's products are available in approximately 13,000 U.S. stores and 3,600 in Canada.[25]

Also in 2019, Tilray entered into an agreement with Natura Naturals Holdings which owns 155,000 square feet of licensed cultivation greenhouses in Leamington, Ontario.[27] The acquisition doubled the cultivation ability of the company in Canada.[28] In May 2020, Tilray announced closure of the High Park Gardens site (previously Natura Naturals) for cost reductions.[29]

In July 2019, Tilray acquired U.K.-based Smith & Sinclair to develop CBD-infused edibles.[30] In August 2019, Tilray acquired Alberta cannabis retailer, Four20.[31]

On April 10, 2023, Tilray announced an agreement to acquire Hexo Corp. for approximately US$56 million. Hexo shareholders will receive 0.4352 of a share of Tilray common stock in exchange for each share held.[32]

On March 2 2026, Tilray announced a £33m ($44.5 million) deal to acquire British brewer BrewDog's global brand, intellectual property, U.K. brewing facilities, and a network of pubs across the U.K. and Ireland. The deal covers BrewDog's core identity and physical footprint in the U.K., which includes brewing operations and 11 pubs.[33]

Merger with Aphria

On 15 December 2020, Aphria conducted a reverse acquisition of Tilray, creating the largest global cannabis company by revenue and geographic reach.[10][8] The chief executive officer (CEO) of Aphria, Irwin D. Simon, stated that the merger strategy was to capture Tilray's business assets and public trading exposure in the United States and its free trade abilities in Europe, enabling potential for becoming a global operation.[8] Irwin was named as CEO and chairman of the board for the merged company, and Tilray CEO, Brendan Kennedy, will be a member of the board of directors.[8] The merged companies will keep Tilray's name and trade under the Tilray ticker symbol, TLRY, on the NASDAQ exchange.[8]

By combining assets, the new Tilray company will develop craft beer and cannabis-infused beverages in partnership with Anheuser-Busch InBev, and have branded hemp and cannabidiol products.[8] According to one source, the world market potential for cannabis products is $94 billion by 2025.[8]

Brewery ownership

Tilray also owns several breweries: Montauk Brewing Company, Good Supply Beer, 10 Barrel Brewing Company, Square Mile Cider Company, Terrapin Beer Company, Truss Beverage Co and Brewdog breweries.[34] Tilray's beer division ranked No. 9 on the Brewers Association's annual report of the US nation's top craft companies based on beer sales volume in 2022.[35][36][37]

Alpine Beer Company

Founded in 1999 in Alpine, California, the Alpine Beer Company produced award-winning sour beers.[38][39] The company would be acquired by the Green Flash Brewing Company in 2014 and continued existence as a brand.[40]

Blue Point Brewing Company

Founded in a former ice factory in 1998 to fill the niche of a Long Island focused Microbrewery.[41] The company's flagship "Toasted Lager" won a gold medal at the 2006 World Beer Cup in the American-Style Amber Lager category.[42] The company distributed their beer to 19 states and Washington D.C. before being purchased by Anheuser-Busch InBev on February 5, 2014, for nearly $24 million. Citing financial shortfall in part due to the 2023 Bud Light boycott, Anheuser-Busch sold the brand to Tilray in August 2023.[43]

Breckenridge Brewery

Founded in Breckenridge, Colorado in 1990 as the state's third craft brewery before moving most of their production to Denver in 1992.[44][45] In 2010 the company merged with the Wynkoop Brewing Company and purchased the Phantom Canyon Brewing company to become the Breckenridge-Wynkoop LLC.[46] In 2015 they moved to a new facility in Littleton, Colorado and was producing 70,000 barrels of beer per year.[47] On December 22, 2015, Anheuser-Busch InBev announced its intent to purchase just Breckenridge Brewery from Breckenridge-Wynkoop LLC, splitting the companies with the purchase finalizing in 2016.[48] Anheuser-Busch sold the brand to Tilray in August 2023.[43]

Green Flash Brewing Company

Founded in 2002 in Vista, California before moving to San Diego in 2011.[49] The company operated a 44,000 barrel per year facility in San Diego in 2011, and a 100,000 barrel per year facility in Virginia Beach, Virginia in 2013.[50][51] By 2014 their beer was being sold in all 50 states, as well as internationally and they purchased the Alpine Beer Company.[52][40] The company peaked in 2016 when it was the 37th largest producer of beer in the United States, afterwards the company began a rapid decline due to the rise of rival craft beer producers.[53] In 2018 they cut distribution internationally and to 42 states and laid off 15% of their workforce and defaulted on their loans to construct the Virginia Beach facility.[54][55] The company would be sold to a group of private investors by the end of the year, who would sell the company to Tilray in 2020.[56]

Redhook Ale Brewery

Founded in Seattle in 1981, Redhook specializes in the production of India pale ales.[57] A founding member of the Craft Brew Alliance, the company's distribution rights were bought by Cisco Brewers in 2018.[58] In 2019 the Craft Brew Alliance, and its properties, were acquired by Anheuser-Busch InBev with Redhook operating as a brand.[59] Anheuser-Busch sold the brand to Tilray in August 2023.[43]

Shock Top

A Belgian-Style, spiced Witbeer brand introduced as a seasonal beer by Anheuser-Busch in February 2006, however, the beer's popularity quickly grew and was used as a rival to Molson Coors' Blue Moon. The brand entered a decline following a failed rebranding effort in 2017 and, citing financial shortfall in part due to the 2023 Bud Light boycott, Anheuser-Busch sold the brand to Tilray in August 2023.[43]

SweetWater Brewing Company

A craft brewery founded in 1997 by Freddy Bensch and Kevin McNerney in Atlanta, Georgia.[60] SweetWater's beers are unpasteurized and distribution is limited to select states. SweetWater would be acquired by Aphria In November 2020 for $300 million.[61] Later, in December 2020, Aphria merged with Tilray bringing SweetWater under Tilray's ownership.[8]

Widmer Brothers Brewery

Founded in 1984 in Portland, Oregon, the company primarily produced Hefeweizen.[62] In 2007 Widmer and Redhook announced that they were going to merge to form the Craft Brewers Alliance, which was renamed to the Craft Brew Alliance in 2012.[63] The goal of which was to offer smaller regional beers a national distribution network. In 2019 Widmer and the whole of the Craft Brew Alliance was bought by Anheuser-Busch InBev, with Widmer operating as a brand.[59] Anheuser-Busch sold the brand to Tilray in August 2023.[43]

Food and drink

HiBall Energy

HiBall Energy was founded in 2005 by Todd Berardi and was based out of San Francisco. They produced organic energy drinks and were purchased by Anheuser-Busch on July 20, 2017, in an effort to diversify into non-alcoholic beverages. Their products were low in sugar, produced with fair-trade ingredients, and were available at 14,000 locations prior to its acquisition by Anheuser-Busch.[64] On May 19, 2023, Anheuser-Busch announced that they were discontinuing HiBall alongside their box wine brand Babe Wine, stating that they will be focusing on their "mega brands" instead. This came despite HiBall having a dedicated consumer fan-base that heavily protested the discontinuation. An Anheuser-Busch spokesmen stated that the discontinuation had nothing to do with the 2023 Bud Light boycott.[65][66] Anheuser-Busch sold the HiBall brand to Tilray alongside seven of their beer brands in August 2023.[67]

Preliminary clinical research

In partnership with University of Sydney, NSW Government, Chris O'Brien Lifehouse, Tilray participated in a clinical trial testing the efficacy and tolerability of medical cannabis as a possible treatment for the side effects of chemotherapy.[68] Led by The Hospital for Sick Children, in Toronto, Canada, Tilray provided a cannabidiol (CBD) oil product available in Canada to test the efficacy and tolerability of medical cannabis oil as a possible treatment for pediatric epilepsy (Dravet syndrome).[69] In partnership with the University of British Columbia, Tilray provided medical cannabis products used to test medical cannabis as a possible treatment for post-traumatic stress disorder.[70] In partnership with the Grupo Español de Investigación en Neurooncología GEINO, in Spain, Tilray supplied medical cannabis products for the trial testing the efficacy and tolerability of medical cannabis as a possible treatment for glioblastoma.

In 2019, Tilray signed an agreement with Cannamedical Pharma GmbH to export $3.3 million worth of medical cannabis from its Portugal facility to Germany, marking Tilray's first export from Tilray Portugal Unipessoal, Lda.[71] Tilray also has a research partnership with Coimbra University in Portugal.[72]

In August 2019, Tilray announced a partnership with New York University to study the potential ability of CBD to treat alcohol use disorder and post-traumatic stress disorder.[73] In partnership with New York University, Tilray supplied CBD for a clinical trial studying its possible efficacy for treating disorders caused by breast cancer treatments.[74]

See also

External links

References

  1. Tilray Focuses on Brand Growth in Crowded Canada Pot Market Bloomberg, January 10, 2022, retrieved 2022-03-01^
  2. Tilray Brands, Inc. Class 2 Common Stock (TLRY)^
  3. SmallCapPower. Tilray Stands Out with its Global Supply Agreements 8 August 2018^
  4. Tilray exports medical cannabis to New Zealand for national dispersal Marijuana Business Daily, 2 October 2017^
  5. Tilray sets up Latin American subsidiary Seeking Alpha, 3 December 2018^
  6. Commodities, Agriculture. Tilray to build $30 million EU cannabis production operation in Portugal - Financial Post 7 September 2017^
  7. Tony Owusu. Tilray Stock: As Germany Closes in on Legal Cannabis, Rest of Europe Might Follow TheStreet, January 12, 2022, retrieved 2022-03-01^
  8. Tiffany Kary. Aphria, Tilray combine to create biggest cannabis company Bloomberg, 2020-12-15, retrieved 2021-01-15^
  9. Tilray Commences Trading on the Toronto Stock Exchange Under Symbol "TLRY" National Post, May 5, 2021^
  10. Tilray's Takeover Cannabis Business Times, retrieved 2022-03-04^
  11. Seattle's Privateer launches $100M IPO for its Canadian marijuana company Seattle Times, 20 June 2018, retrieved 15 January 2021^
  12. Tilray, Inc. US Securities and Exchange Commission, 31 December 2018, retrieved 15 January 2021^
  13. Max A. Cherney. Tilray IPO: Five things to know about the first pot company to go public on Nasdaq MarketWatch^
  14. Tilray shows the highs, lows of investing in pot retrieved 2018-09-19^
  15. How the Canadian cannabis company Tilray became worth more than American Airlines Vox, retrieved 2018-09-19^
  16. Shares of pot company Tilray surge in first day of trading on Nasdaq CBC, 19 July 2018, retrieved 15 January 2021^
  17. Canadian producer Tilray to export medical cannabis to U.S. for clinical trial - Globalnews.ca globalnews.ca, 18 September 2018^
  18. Borchard D (Dec. 2018). "Tilray Signs Deal With Big Pharma Company Sandoz". Green Market Report. Retrieved 2018-12-18.^
  19. Tilray Launches High Park Company to Produce and Distribute Adult-Use Cannabis in Canada www.tilray.ca, retrieved 2019-01-18^
  20. Tilray Medical Receives Approval to Extend Market Authorization in Italy September 22, 2022^
  21. Hudson Lindenberger. Tilray Brands Deal With Anheuser-Busch InBev Sets Them Firmly On The National Stage Forbes, retrieved 2024-06-11^
  22. Cannabis. Big Pharma's first foray into cannabis arrives with Sandoz-Tilray deal 2018-03-19, retrieved 2019-02-12^
  23. Brewer AB InBev partners with Tilray to tap cannabis drink market Reuters, 2018-12-19, retrieved 2019-02-12^
  24. Cannabis. Tilray signs creative $250-million revenue-sharing deal with U.S. brand powerhouse ABG 2019-01-15, retrieved 2019-02-12^
  25. Beth Kaiserman. Tilray Eyes CBD Food And Drink Market With Manitoba Harvest Acquisition Forbes, retrieved 2019-07-26^
  26. Solomon Israel. Manitoba Harvest enters 'wild, wild west' CBD market in U.S. Winnipeg Free Press, 2019-05-31, retrieved 2019-07-26^
  27. Tilray to Acquire Natura Naturals Holdings Inc. for up to C$70 Million Subject to Performance Milestones Tilray, retrieved 2019-02-27^
  28. Tilray to buy Natura for up to $70M, doubling Canadian cannabis growing capacity www.ctvnews.ca, January 22, 2019, retrieved 2019-04-01^
  29. High Park Gardens Licensed Cannabis Greenhouse In Leamington To Close windsorite.ca, retrieved 2020-07-28^
  30. Angelica LaVito. Tilray acquires boozy candy company Smith & Sinclair to develop CBD edibles CNBC, 2019-07-23, retrieved 2019-07-26^
  31. Tilray signs deal to acquire Alberta cannabis retailer Four20 BNN Bloomberg, The Canadian Press, 2019-08-29, retrieved 2020-01-19^
  32. Tilray Brands Reports Third Quarter Fiscal Year 2023 Financial Results and Announces Accretive Acquisition of 100% of HEXO Corp. Yahoo Finance, April 10, 2023, retrieved 2023-04-10^
  33. Craig Williams. Bars close and hundreds lose jobs as US firm buys Brewdog in £33m deal BBC News, BBC Scotland, 2 March 2026^
  34. Tilray Brands Announces Agreement to Acquire Eight Beer & Beverage Brands From Anheuser-Busch, Fueling Tilray's Future in the U.S. Craft Beer Industry Globe Newswire, August 7, 2023^
  35. Cannabis producer Tilray makes US list of largest craft brewers^
  36. Brewers Association. Brewers Association Releases Annual Craft Brewing Industry Production Report and Top 50 Producing Craft Brewing Companies for 2022 Brewers Association, 2023-04-18, retrieved 2023-08-09^
  37. Tilray Brands Announces Acquisition of Truss Beverage Co.™ August 18, 2023^
  38. Sour beer? Pucker up Los Angeles Times, July 1, 2009, retrieved 2009-08-31^
  39. San Diego Union-Tribune San Diego Union-Tribune, October 1, 2024^
  40. Peter Rowe, "Green Flash acquires Alpine," San Diego Union-Tribune, November 10, 2014.^
  41. LARGE CRAFT BREWERY: Blue Point Brewing Co. Long Island Beer, retrieved 22 May 2012^
  42. Past Winners Lists - World Beer Cup World Beer Cup, retrieved 2015-12-24^
  43. Janet Freund. Tilray to Buy Eight Beverage Brands for $85 Million From AB InBev Bloomberg News, August 8, 2023, retrieved 22 August 2023^
  44. Elizabeth J. Goodgold, "Brand-Spankin' Brew," Entrepreneur, January 2003.^
  45. Lee Williams, "Behind the Scenes at Breckenridge Brewing Co., Denver, Colorado," Serious Eats, May 13, 2012.^
  46. Jonathan Shikes, "Breckenridge Brewery's Todd Usry Explains the Sale to Anheuser-Busch InBev," Westword, December 23, 2015.^
  47. Clayton Woullard, "Littleton hopes new Breckenridge Brewery becomes tourist draw," Denver Post, November 25, 2014.^
  48. "Anheuser-Busch InBev Buys Large Colorado Craft Beer Brewery," The New York Times, December 23, 2015.^
  49. Lou Hirsh, "Green Flash Brewing Names Ross as COO," San Diego Business Journal, September 3, 2015.^
  50. Peter Rowe. Prepare to see more -- much more -- Green Flash Sign On San Diego, May 3, 2011, retrieved May 4, 2011^
  51. Greg Kitsock, "Green Flash announces East Coast brewery in Virginia Beach," Washington Post, March 14, 2013.^
  52. Green Flash, St-Feuillien reach deal to have West Coast IPA brewed, sold in Europe - BeerPulse July 21, 2014^
  53. Tarcy Connors. Three S.D. County Breweries Make Top 50 List San Diego Business Journal, March 15, 2017, retrieved 16 March 2017^
  54. Justin Kendall. Green Flash Pulls Distribution From 32 States, Eliminates 15 Percent of Workforce Brewbound, January 15, 2018^
  55. Peter Rowe. Beer bust: Green Flash closes Virginia Beach brewery San Diego Union Tribune, March 26, 2018^
  56. Tilray Acquired Green Flash and Alpine for $5.1M; Dissolves Anheuser-Busch InBev JV January 10, 2022^
  57. Redhook Brewlab^
  58. Karen Dandurant. Redhook being replaced by Cisco Brewers at Pease seacoastonline.com, June 15, 2018, retrieved 2018-10-11^
  59. Mike Rogoway. Anheuser-Busch buys total control of Portland's Craft Brew Alliance for $220 million The Oregonian, November 11, 2019, retrieved November 11, 2019^
  60. Jill Martin. Small Beer: US Brewers With Big Passion To Succeed BBC News, 12 June 2013, retrieved 13 June 2013^
  61. Aphria Inc. Closes Accretive, Strategic Acquisition of Sweetwater Brewing Company Aphria Inc., retrieved 2021-02-07^
  62. Answers - The Most Trusted Place for Answering Life's Questions Answers^
  63. Redhook, Widmer Brothers will merge, but keep brands - seattlepi.com^
  64. Mike Snider. Anheuser-Busch buys drink maker Hiball Energy USA Today, retrieved 9 September 2023^
  65. Eszter Racz. Anheuser-Busch InBev discontinues Babe wine, Hiball energy drinks just-drinks.com, May 19, 2023, retrieved 9 September 2023^
  66. Nicolette Baker. Anheuser-Busch Discontinues Babe Wine, HiBall Energy Seltzer vinepair.com, retrieved 9 September 2023^
  67. Julie Hyman, Stephanie Mikulich. Tilray stock pops on purchase of eight brands from Anheuser-Busch Yahoo! Finance, August 8, 2023, retrieved 9 September 2023^
  68. Medicinal Cannabis Factsheet^
  69. First Canadian paediatric study of mixed THC/CBD cannabis oil shows promise for children with drug-resistant epilepsy SickKids, The Hospital for Sick Children, retrieved 2019-02-12^
  70. UBC & Tilray Launch Clinical Trial to Study Medical Cannabis & PTSD - Business Examiner www.businessexaminer.ca, September 8, 2016, retrieved 2019-02-13^
  71. Max A. Cherney. Tilray signs first deal to supply pot to Europe out of new Portugal facility MarketWatch, retrieved 2019-08-21^
  72. Daphne Freeman. Tilray partners with Coimbra University to study medical cannabis Born2Invest, 2019-12-19, retrieved 2020-01-19^
  73. Angelica LaVito. Canadian pot company Tilray ships CBD to US for clinical trials on alcohol and PTSD CNBC, 2019-08-08, retrieved 2019-08-08^
  74. Gregory Calderone Bloomberg, 24 October 2019, retrieved 15 January 2021^